Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pleural Effusion, Malignant × Doxycycline × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 2 Immunoglobulin Light-chain Amyloidosis 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pain 1 Myoma 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Head and Neck Neoplasms 1 Exanthema 1 Endometritis 1 Colorectal Neoplasms 1 Amyloidosis, Familial 1 Advanced Malignant Neoplasm 1 AA amyloidosis 1

Interventions

Paclitaxel 4 Cisplatin 4 Carboplatin 4 Taxes 3 Docetaxel 3 Bevacizumab 3 Gemcitabine 2 Fluorodeoxyglucose F18 2 Drug Therapy 2 endostar protein 1 cediranib 1 Zoledronic Acid 1 X-Rays 1 Vinorelbine 1 Thoracic Surgery, Video-Assisted 1 Spectrum Analysis 1 Silver Nitrate 1 Saline Solution 1 Radiotherapy, Conformal 1 Pleurodesis 1 Pemetrexed 1 Nivolumab 1 Naproxen 1 Morphine 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Immunohistochemistry 1 Imatinib Mesylate 1 Ibuprofen 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡